NCT03432442View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics of Ivermectin in Pediatric Dengue Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 4, 2018

Primary Completion Date

September 22, 2020

Study Completion Date

September 22, 2020

Conditions
Dengue Hemorrhagic Fever
Interventions
DRUG

Ivermectin

Ivermectin once every 24 hours for three administrations

Trial Locations (1)

10700

Faculty of Tropical Medicine Siriraj Hospital, Bangkok Noi

All Listed Sponsors
lead

Mahidol University

OTHER

NCT03432442 - Pharmacokinetics and Pharmacodynamics of Ivermectin in Pediatric Dengue Patients | Biotech Hunter | Biotech Hunter